Takeda Pharmaceutical (TAK) Non-cash Items (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Non-cash Items of $885.2 million for Q2 2026, down 48.44% year-over-year from $1.7 billion in Q2 2025, and little changed quarter-over-quarter from $884.1 million in Q1 2026.
Takeda Pharmaceutical (TAK) Non-cash Items (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Non-cash Items history runs 9 years deep, the most recent figure standing at $885.2 million for Q2 2026.
- In Q2 2026, Non-cash Items fell 48.44% year-over-year to $885.2 million; the TTM figure through Jun 2026 stood at $7.3 billion (down 12.88% YoY), while the FY2026 annual figure was $8.1 billion, up 1.73% from the prior year.
- Non-cash Items for Q2 2026 stood at $885.2 million, roughly flat from $884.1 million in the prior quarter.
- The five-year high for Non-cash Items was $3.6 billion in Q1 2022, with the low at $812.7 million in Q2 2022.
- The 5-year median for Non-cash Items is $2.0 billion (2023), against an average of $2.0 billion.
- The sharpest annual moves came in 2023 and 2024: Non-cash Items slumped 57.32% in 2023, then jumped 101.18% in 2024.
- Takeda Pharmaceutical's Non-cash Items stood at $3.1 billion in 2022, then plunged by 57.32% to $1.3 billion in 2023, then surged by 101.18% to $2.6 billion in 2024, then dropped by 2.62% to $2.6 billion in 2025, then sank by 65.54% to $885.2 million in 2026.
- Business Quant data shows TAK's Non-cash Items at $885.2 million in Q2 2026, $884.1 million in Q1 2026, and $2.6 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 885.15 Mn |
| Jun 30, 2026 | 885.15 Mn |
| Mar 31, 2026 | 884.10 Mn |
| Mar 31, 2026 | 884.10 Mn |
| Dec 31, 2025 | 2.57 Bn |
| Dec 31, 2025 | 2.57 Bn |
| Sep 30, 2025 | 2.93 Bn |
| Sep 30, 2025 | 2.93 Bn |
| Jun 30, 2025 | 1.72 Bn |
| Jun 30, 2025 | 1.72 Bn |
| Mar 31, 2025 | 1.77 Bn |
| Mar 31, 2025 | 1.77 Bn |
| Dec 31, 2024 | 2.64 Bn |
| Dec 31, 2024 | 2.64 Bn |
| Sep 30, 2024 | 2.21 Bn |
| Sep 30, 2024 | 2.21 Bn |
| Jun 30, 2024 | 1.32 Bn |
| Jun 30, 2024 | 1.32 Bn |
| Mar 31, 2024 | 2.12 Bn |
| Mar 31, 2024 | 2.12 Bn |